# Lesaka Technologies Inc: financial statements, quarterly

LSAK · Nasdaq · CIK 1041514 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/lsak.md) · [Financials](/companies/lsak/financials.md) · [Filings](/companies/lsak/filings.md) · [Insiders](/companies/lsak/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lsak/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [136](/filings/0001562762-25-000239.md) | [144](/filings/0001562762-25-000241.md) | [138](/filings/0001562762-25-000243.md) | [146 d](/filings/0001562762-26-000104.md) | [154](/filings/0001562762-25-000264.md) | [176](/filings/0001562762-26-000015.md) | [161](/filings/0001562762-26-000058.md) | [168 d](/filings/0001562762-26-000104.md) | [171](/filings/0001562762-25-000264.md) | [179](/filings/0001562762-26-000015.md) | [183](/filings/0001562762-26-000058.md) | [188 d](/filings/0001562762-26-000104.md) |
| Cost of revenue | $m | [107](/filings/0001562762-25-000239.md) | [114](/filings/0001562762-25-000241.md) | [108](/filings/0001562762-25-000243.md) | [114 d](/filings/0001562762-26-000104.md) | [119](/filings/0001562762-25-000264.md) | [131](/filings/0001562762-26-000015.md) | [117](/filings/0001562762-26-000058.md) | [120 d](/filings/0001562762-26-000104.md) | [118](/filings/0001562762-25-000264.md) | [123](/filings/0001562762-26-000015.md) | [124](/filings/0001562762-26-000058.md) | [126 d](/filings/0001562762-26-000104.md) |
| Selling, general and administrative | $m | [22.5](/filings/0001562762-25-000239.md) | [21.5](/filings/0001562762-25-000241.md) | [23.1](/filings/0001562762-25-000243.md) | [19.9 d](/filings/0001562762-26-000104.md) | [26.7](/filings/0001562762-25-000264.md) | [33.8](/filings/0001562762-26-000015.md) | [32.6](/filings/0001562762-26-000058.md) | [32.0 d](/filings/0001562762-26-000104.md) | [39.6](/filings/0001562762-25-000264.md) | [36.1](/filings/0001562762-26-000015.md) | [39.2](/filings/0001562762-26-000058.md) | [41.1 d](/filings/0001562762-26-000104.md) |
| Operating income | $m | [0.2](/filings/0001562762-25-000239.md) | [2.3](/filings/0001562762-25-000241.md) | [0.8](/filings/0001562762-25-000243.md) | [(0.5) d](/filings/0001562762-26-000104.md) | [(0.0)](/filings/0001562762-25-000264.md) | [0.5](/filings/0001562762-26-000015.md) | [0.4](/filings/0001562762-26-000058.md) | [(28.6) d](/filings/0001562762-26-000104.md) | [0.4](/filings/0001562762-25-000264.md) | [2.2](/filings/0001562762-26-000015.md) | [4.1](/filings/0001562762-26-000058.md) | [6.3 d](/filings/0001562762-26-000104.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.3](/filings/0001562762-25-000239.md) | [0.7](/filings/0001562762-25-000241.md) | [0.9](/filings/0001562762-25-000243.md) | [1.5 d](/filings/0001562762-26-000104.md) | [0.1](/filings/0001562762-25-000264.md) | [(6.4)](/filings/0001562762-26-000015.md) | [(2.9)](/filings/0001562762-26-000058.md) | [(6.7) d](/filings/0001562762-26-000104.md) | [(0.1)](/filings/0001562762-25-000264.md) | [0.7](/filings/0001562762-26-000015.md) | [1.5](/filings/0001562762-26-000058.md) | [(0.6) d](/filings/0001562762-26-000104.md) |
| Net income | $m | [(5.7)](/filings/0001562762-25-000239.md) | [(2.7)](/filings/0001562762-25-000241.md) | [(4.0)](/filings/0001562762-25-000243.md) | [(6.1) d](/filings/0001562762-26-000104.md) | [(4.5)](/filings/0001562762-25-000264.md) | [(32.5)](/filings/0001562762-26-000015.md) | [(22.4)](/filings/0001562762-26-000058.md) | [(31.3) d](/filings/0001562762-26-000104.md) | [(4.3)](/filings/0001562762-25-000264.md) | [3.6](/filings/0001562762-26-000015.md) | [0.6](/filings/0001562762-26-000058.md) | [3.2 d](/filings/0001562762-26-000104.md) |
| Diluted EPS | $ per share | [(0.09)](/filings/0001562762-25-000239.md) | [(0.04)](/filings/0001562762-25-000241.md) | [(0.06)](/filings/0001562762-25-000243.md) | not reported | [(0.07)](/filings/0001562762-25-000264.md) | [(0.40)](/filings/0001562762-26-000015.md) | [(0.28)](/filings/0001562762-26-000058.md) | not reported | [(0.05)](/filings/0001562762-25-000264.md) | [0.04](/filings/0001562762-26-000015.md) | [0.01](/filings/0001562762-26-000058.md) | not reported |
| Basic EPS | $ per share | [(0.09)](/filings/0001562762-25-000239.md) | [(0.04)](/filings/0001562762-25-000241.md) | [(0.06)](/filings/0001562762-25-000243.md) | not reported | [(0.07)](/filings/0001562762-25-000264.md) | [(0.40)](/filings/0001562762-26-000015.md) | [(0.28)](/filings/0001562762-26-000058.md) | not reported | [(0.05)](/filings/0001562762-25-000264.md) | [0.04](/filings/0001562762-26-000015.md) | [0.01](/filings/0001562762-26-000058.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [44.3](/filings/0001562762-25-000241.md) | [55.2](/filings/0001562762-25-000243.md) | [59.1](/filings/0001562762-26-000104.md) | [49.7](/filings/0001562762-25-000264.md) | [60.6](/filings/0001562762-26-000015.md) | [71.0](/filings/0001562762-26-000058.md) | [76.5](/filings/0001562762-26-000104.md) | [72.2](/filings/0001562762-25-000264.md) | [69.5](/filings/0001562762-26-000015.md) | [90.6](/filings/0001562762-26-000058.md) | [81.4](/filings/0001562762-26-000104.md) |
| Current assets | $m | [173](/filings/0001562762-23-000403.md) | [203](/filings/0001562762-24-000021.md) | [186](/filings/0001562762-24-000130.md) | [188](/filings/0001562762-25-000245.md) | [167](/filings/0001562762-25-000239.md) | [211](/filings/0001562762-25-000241.md) | [212](/filings/0001562762-25-000243.md) | [244](/filings/0001562762-26-000104.md) | [241](/filings/0001562762-25-000264.md) | [285](/filings/0001562762-26-000015.md) | [275](/filings/0001562762-26-000058.md) | [268](/filings/0001562762-26-000104.md) |
| Total assets | $m | [547](/filings/0001562762-23-000403.md) | [581](/filings/0001562762-24-000021.md) | [551](/filings/0001562762-24-000130.md) | [558](/filings/0001562762-25-000245.md) | [552](/filings/0001562762-25-000239.md) | [641](/filings/0001562762-25-000241.md) | [649](/filings/0001562762-25-000243.md) | [651](/filings/0001562762-26-000104.md) | [653](/filings/0001562762-25-000264.md) | [705](/filings/0001562762-26-000015.md) | [675](/filings/0001562762-26-000058.md) | [699](/filings/0001562762-26-000104.md) |
| Current liabilities | $m | [109](/filings/0001562762-23-000403.md) | [129](/filings/0001562762-24-000021.md) | [116](/filings/0001562762-24-000130.md) | [130](/filings/0001562762-25-000245.md) | [109](/filings/0001562762-25-000239.md) | [239](/filings/0001562762-25-000241.md) | [155](/filings/0001562762-25-000243.md) | [164](/filings/0001562762-26-000104.md) | [149](/filings/0001562762-25-000264.md) | [182](/filings/0001562762-26-000015.md) | [179](/filings/0001562762-26-000058.md) | [169](/filings/0001562762-26-000104.md) |
| Total liabilities | $m | [292](/filings/0001562762-23-000403.md) | [320](/filings/0001562762-24-000021.md) | [299](/filings/0001562762-24-000130.md) | [303](/filings/0001562762-25-000245.md) | [288](/filings/0001562762-25-000239.md) | [352](/filings/0001562762-25-000241.md) | [368](/filings/0001562762-25-000243.md) | [396](/filings/0001562762-26-000104.md) | [387](/filings/0001562762-25-000264.md) | [428](/filings/0001562762-26-000015.md) | [404](/filings/0001562762-26-000058.md) | [415](/filings/0001562762-26-000104.md) |
| Long-term debt | $m | [131](/filings/0001562762-23-000403.md) | [139](/filings/0001562762-24-000021.md) | [132](/filings/0001562762-24-000130.md) | [127](/filings/0001562762-25-000245.md) | [132](/filings/0001562762-25-000239.md) | [68.9](/filings/0001562762-25-000241.md) | [167](/filings/0001562762-25-000243.md) | [189](/filings/0001562762-26-000104.md) | [196](/filings/0001562762-25-000264.md) | [204](/filings/0001562762-26-000015.md) | [186](/filings/0001562762-26-000058.md) | [195](/filings/0001562762-26-000104.md) |
| Current portion of debt | $m | [3.6](/filings/0001562762-23-000403.md) | [3.4](/filings/0001562762-24-000021.md) | [3.3](/filings/0001562762-24-000130.md) | [15.7](/filings/0001562762-25-000245.md) | [16.4](/filings/0001562762-25-000239.md) | [79.8](/filings/0001562762-25-000241.md) | [28.1](/filings/0001562762-25-000243.md) | [12.0](/filings/0001562762-26-000104.md) | [12.6](/filings/0001562762-25-000264.md) | [13.0](/filings/0001562762-26-000015.md) | [15.3](/filings/0001562762-26-000058.md) | [16.1](/filings/0001562762-26-000104.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [175](/filings/0001562762-23-000403.md) | [181](/filings/0001562762-24-000021.md) | [173](/filings/0001562762-24-000130.md) | [176](/filings/0001562762-25-000245.md) | [184](/filings/0001562762-25-000239.md) | [193](/filings/0001562762-25-000241.md) | [185](/filings/0001562762-25-000243.md) | [159](/filings/0001562762-26-000104.md) | [170](/filings/0001562762-25-000264.md) | [181](/filings/0001562762-26-000015.md) | [187](/filings/0001562762-26-000058.md) | [205](/filings/0001562762-26-000104.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.4](/filings/0001562762-25-000239.md) | [0.6](/filings/0001562762-25-000241.md) | [19.2](/filings/0001562762-25-000243.md) | [5.7 d](/filings/0001562762-26-000104.md) | [(4.1)](/filings/0001562762-25-000264.md) | [(9.2)](/filings/0001562762-26-000015.md) | [10.7](/filings/0001562762-26-000058.md) | [(6.5) d](/filings/0001562762-26-000104.md) | [8.9](/filings/0001562762-25-000264.md) | [(10.9)](/filings/0001562762-26-000015.md) | [37.6](/filings/0001562762-26-000058.md) | [16.9 d](/filings/0001562762-26-000104.md) |
| Capital expenditure | $m | [2.8](/filings/0001562762-25-000239.md) | [2.2](/filings/0001562762-25-000241.md) | [2.9](/filings/0001562762-25-000243.md) | [4.7 d](/filings/0001562762-26-000104.md) | [4.0](/filings/0001562762-25-000264.md) | [6.3](/filings/0001562762-26-000015.md) | [2.8](/filings/0001562762-26-000058.md) | [4.1 d](/filings/0001562762-26-000104.md) | [4.0](/filings/0001562762-25-000264.md) | [3.9](/filings/0001562762-26-000015.md) | [3.4](/filings/0001562762-26-000058.md) | [9.3 d](/filings/0001562762-26-000104.md) |
| Share repurchases | $m | [0.0](/filings/0001562762-23-000403.md) | [0.2](/filings/0001562762-25-000241.md) | [0.0](/filings/0001562762-25-000243.md) | [1.3 d](/filings/0001562762-26-000104.md) | not reported | [12.6](/filings/0001562762-26-000015.md) | [0.0](/filings/0001562762-26-000058.md) | [1.0 d](/filings/0001562762-26-000104.md) | not reported | [0.3](/filings/0001562762-26-000015.md) | [0.0](/filings/0001562762-26-000058.md) | [0.0 d](/filings/0001562762-26-000104.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.1](/filings/0001562762-23-000403.md) | [60.2](/filings/0001562762-24-000021.md) | [61.5](/filings/0001562762-24-000130.md) | [0.1](/filings/0001562762-25-000239.md) | [61.0](/filings/0001562762-25-000241.md) | [61.0](/filings/0001562762-25-000243.md) | [0.1](/filings/0001562762-25-000264.md) | [77.0](/filings/0001562762-26-000015.md) | [78.3](/filings/0001562762-26-000058.md) | [0.1](/filings/0001562762-25-000264.md) | [80.1](/filings/0001562762-26-000015.md) | [79.5](/filings/0001562762-26-000058.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 85,824,094 at 2026-09-09, from the cover of the [10-K filed 2026-09-09](/filings/0001562762-26-000104.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.